Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 27, 2021
Patent Application Number
16264201
Date Filed
January 31, 2019
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided herein are anti-PD-1/LAG3 bispecific antibodies and antigen-binding fragments. Also provided here are methods and uses of these antibodies and antigen-binding fragments in the treatment of cancer or infectious disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
